Isolation of Nbutylbenzenesulfonamide, synthesis of benzenesulfonamide derivatives, and use of N-butylbenzenesulfonamide and benzenesulfonamide derivatives for the treatment of benign prostate hyperplasia and/or prostate carcinoma

Details for Australian Patent Application No. 2006210040 (hide)

Owner LTS Lohmann Therapie-Systeme AG

Inventors Hoffmann, Hans-Rainer; Baniahmad, Aria; Matusch, Rudolf

Agent Davies Collison Cave

Pub. Number AU-B-2006210040

PCT Pub. Number WO2006/081994

Priority 10 2005 005 397.1 05.02.05 DE

Filing date 28 January 2006

Wipo publication date 10 August 2006

Acceptance publication date 14 April 2011

International Classifications

A61K 31/18 (2006.01) - Sulfonamides

A61K 36/00 (2006.01) Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines

A61P 13/08 (2006.01) Drugs for disorders of the urinary system

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

23 August 2007 PCT application entered the National Phase

  PCT publication WO2006/081994 Priority application(s): WO2006/081994

14 April 2011 Application Accepted

  Published as AU-B-2006210040

11 August 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006210041-Device and method for the elimination of magnetic or magnetizable particles from a liquid

2006210029-Permanent mould for casting light metal casting materials and use of said type of permanent mould and a casting material